HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization.

AbstractBACKGROUND:
Hepatocellular carcinoma (HCC) with main portal vein tumor thrombus (MPVTT) is often associated with poor prognosis. We retrospectively assessed the effectiveness of percutaneous transhepatic portal vein stenting and transarterial chemoembolization (PTPVS-TACE) combined with or without 3-dimensional conformal radiotherapy (3-DCRT) for HCC with MPVTT.
METHODS:
Forty-five patients with HCC complicated by MPVTT were treated with PTPVS-TACE. Among them, 16 patients (group A) received 3-DCRT with 30-60Gy as daily 2Gy fractions. The remaining 29 patients (group B) received no radiotherapy. The tumor responses, complications, stent patency rates, and cumulative survival rates were evaluated, and the Kaplan-Meier method and log-rank test were used for survival analysis.
RESULTS:
No severe complications were associated with PTPVS-TACE and 3-DCRT. The objective response rate (CR and PR) was 35.6%. The 60-, 180-, and 360-day cumulative stent patency rates were 93.3%, 62.2%, and 34.6% in group A, and 58.6%, 21.7%, and 10.8% in group B, respectively, showing significant difference between the 2 groups (P<.01). The mean patency time was 475.20+/-136.97 and 199.58+/-61.40 days, respectively. The 60-, 180-, and 360-day cumulative survival rates were 93.8%, 81.3%, and 32.5%, respectively, for group A, 86.2%, 13.8%, and 6.9%, respectively, for group B. Significant statistical differences were detected between the 2 groups (P<.01).
CONCLUSIONS:
These findings suggest that sequential therapy by PTPVS-TACE-3-DCRT is possibly an effective treatment modality for HCC complicated by main portal vein tumor thrombus.
AuthorsXue-Bin Zhang, Jian-Hua Wang, Zhi-Pin Yan, Sheng Qian, Shi-Suo Du, Zhao-Chong Zeng
JournalCancer (Cancer) Vol. 115 Issue 6 Pg. 1245-52 (Mar 15 2009) ISSN: 0008-543X [Print] United States
PMID19156918 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
CopyrightCopyright (c) 2009 American Cancer Society.
Topics
  • Adult
  • Aged
  • Carcinoma, Hepatocellular (complications, radiotherapy)
  • Chemoembolization, Therapeutic (methods)
  • Combined Modality Therapy
  • Female
  • Humans
  • Liver Neoplasms (complications, radiotherapy)
  • Male
  • Middle Aged
  • Palliative Care
  • Portal Vein (surgery)
  • Radiotherapy, Conformal
  • Stents
  • Survival Analysis
  • Vascular Patency
  • Venous Thrombosis (complications, radiotherapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: